Status:
COMPLETED
Serum Concentration of CEFOxitin Used for Antibiotic Prophylaxis in Obese Patients Undergoing BARiatric Surgery
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Obese
Antibiotic Prophylaxis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Obesity is a pandemic problem in modern societies. Bariatric surgery (gastric by-pass and sleeve gastrectomy) has emerged as an efficient treatment to reduce morbidity and mortality related to obesity...
Eligibility Criteria
Inclusion
- Age ≥ 18 years-old,
- Severely obese patient with a BMI ≥ 35 kg.m-2,
- Scheduled bariatric surgery: gastric by-pass or sleeve gastrectomy,
- Affiliated to social security,
- The patient is able to consent to clinical research and has received all information on the study design/protocol,
- Signed/written informed consent
Exclusion
- Refuse to consent to the study or the patient is unable to consent,
- Allergy/Anaphylaxis to beta-lactam (ß-lactam) antibiotics either proven or suspected,
- Pregnancy,
- Persons deprived of their liberty by judicial or administrative decision,
- Urgent or emergent surgery.
Key Trial Info
Start Date :
October 30 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 9 2018
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03306290
Start Date
October 30 2017
End Date
August 9 2018
Last Update
August 28 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Central Hospital
Vandœuvre-lès-Nancy, France, 54500